Research

Dendritic cells represent an important component of the immune system: they recognize and engulf invaders which subsequently triggers a pathogen-specific immune response. Scientists of the Department of Dermatology and the LIMES Institute of the University of Bonn gained substantial knowledge of human dendritic cells which might contribute to the development of immune therapies in the future.

The Faculty of Medicine welcomes another Humboldt fellow at the Department of Medicine 1, Dr. J. Patankar.

The patient perspective is important in all medical research, and particularly in drug development. This is reflected in the European research initiative PREFER in which a research group at the Department of Medicine 3 is involved.

A study shows a new, surprising role played by blood vessels: under certain conditions they can inhibit tumor growth.

Around 400,000 people in Germany suffer from chronic inflammatory bowel disease. Researchers at the Faculty of Medicine have recently published findings showing that a special technique can improve the examination procedure for the disease.

Around 120 scientists and physicians from different European countries, the US, and Brazil met in Erlangen from July 6 - 9th to take part in the Summer School "Translational kidney research – from physiology to clinical application“.

A team of researchers has taken some important steps towards finding treatments for a specific form of hereditary spastic paraplegia, a group of neurodegenerative diseases for which there is currently no known cure.

Researchers at the Institute of Physiology and Pathophysiology and at the Department of Medicine 1 have identified another substance that could be just as effective at combating severe pain, but is much more easily tolerated.

Researchers have been investigating how tumor necrosis factor (TNF), a messenger substance in the immune system, protects against infection for many years. A new mechanism via which TNF protects against pathogens that cause infection has now been discovered.

Photodynamic therapy is an effective treatment for early-stage skin cancer. However, this therapy can cause patients severe pain. The reason for this was previous a mystery to researchers. Our Physiologists have now discovered that it is due to two specific ion channels.